The method, dubbed GoPhAST-R, was codeveloped by researcher from the Broad Institute and NanoString, which now hopes to work with a partner to commercialize it.
The firm's diagnostics and genomics group saw a 5 percent year-over-year revenue increase in the fourth quarter.
PWNHealth will enable Stratify to offer its Prompt Personal Genetic Score prostate cancer genetic risk test directly to consumers with medical oversight.
A survey by University of Nebraska researchers found that both specialists and primary care healthcare providers largely interpreted genetic testing results correctly.
Athena and its supporters have asked the Supreme Court to clarify patent eligibility, but Mayo recently countered that this is a job for legislators.
Asuragen will use its Amplidex PCR tech to develop companion diagnostics for Wave's investigational allele-selective therapeutic programs for Huntington's.
In May, the company received a delisting warning from Nasdaq after its stock closed between the minimum $1 per share requirement for 30 days.
Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.
The grant will support the development of a high-throughput method to extract and test dried blood samples collected by patients at home.
The company's point-of-care platform combines clinical chemistry, immunoassays, and hematology technology to run a range of diagnostic tests.